Artisan Partners’s HOOKIPA Pharma HOOK Stock Holding History

Artisan Partners’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-14,260	Closed	-$1.18M	–	315
2020 Q1	$1.18M	Sell	14,260 -197	-1%	-$21.6K	﹤0.01%	298
2019 Q4	$1.77M	Hold	14,457	–	–	﹤0.01%	290
2019 Q3	$1.08M	Buy	14,457 +1,830	+14%	+$135K	﹤0.01%	284
2019 Q2	$850K	Buy	+12,627	New	+$1.34M	﹤0.01%	285

Other funds holding HOOK

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners's HOOK Position: Q2 2020 in Review

Artisan Partners sold out of HOOKIPA Pharma (HOOK) in Q2 2020, closing a stake of 14,260 shares — an estimated $1.18M sold.

Artisan Partners first reported a position in HOOK in Q2 2019 and held it in 4 quarters. The position peaked at $1.77M in Q4 2019. 47 funds tracked by Wall St. Rank hold HOOK as of Q2 2020.

Artisan Partners reported no remaining HOOKIPA Pharma position as of Q2 2020 after selling out during the quarter.
Artisan Partners sold 14,260 HOOKIPA Pharma shares in Q2 2020, an estimated $1.18M.
Artisan Partners first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 4 quarters.
Artisan Partners's HOOKIPA Pharma position peaked at $1.77M in Q4 2019.
47 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2020.

Based on Artisan Partners's 13F filing for Q2 2020, filed 12 Aug 2020.